vs
OPKO HEALTH, INC.（OPK）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
BRC Group Holdings, Inc.的季度营收约是OPKO HEALTH, INC.的1.3倍（$188.3M vs $148.5M），BRC Group Holdings, Inc.净利率更高（47.9% vs -21.1%，领先69.0%），OPKO HEALTH, INC.同比增速更快（-19.2% vs -21.9%），过去两年OPKO HEALTH, INC.的营收复合增速更高（-7.5% vs -15.4%）
OPKO Health是一家聚焦诊断与医药领域的医疗企业，核心业务涵盖医疗检测与药品研发生产，在纳斯达克和特拉维夫证券交易所挂牌上市，股票代码为OPK。
OPK vs RILY — 直观对比
营收规模更大
RILY
是对方的1.3倍
$148.5M
营收增速更快
OPK
高出2.7%
-21.9%
净利率更高
RILY
高出69.0%
-21.1%
两年增速更快
OPK
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $148.5M | $188.3M |
| 净利润 | $-31.3M | $90.3M |
| 毛利率 | 43.1% | 79.5% |
| 营业利润率 | -25.8% | 32.3% |
| 净利率 | -21.1% | 47.9% |
| 营收同比 | -19.2% | -21.9% |
| 净利润同比 | -322.8% | 1710.8% |
| 每股收益（稀释后） | $-0.04 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OPKRILY
| Q4 25 | $148.5M | $188.3M | ||
| Q3 25 | $151.7M | $215.3M | ||
| Q2 25 | $156.8M | $188.2M | ||
| Q1 25 | $150.0M | $197.2M | ||
| Q4 24 | $183.6M | $241.0M | ||
| Q3 24 | $173.6M | $225.5M | ||
| Q2 24 | $182.2M | $256.0M | ||
| Q1 24 | $173.7M | $263.4M |
净利润OPKRILY
| Q4 25 | $-31.3M | $90.3M | ||
| Q3 25 | $21.6M | $91.1M | ||
| Q2 25 | $-148.4M | $139.5M | ||
| Q1 25 | $-67.6M | $-10.0M | ||
| Q4 24 | $14.0M | $-5.6M | ||
| Q3 24 | $24.9M | $-284.4M | ||
| Q2 24 | $-10.3M | $-433.6M | ||
| Q1 24 | $-81.8M | $-49.2M |
毛利率OPKRILY
| Q4 25 | 43.1% | 79.5% | ||
| Q3 25 | 32.9% | 83.7% | ||
| Q2 25 | 31.5% | 81.3% | ||
| Q1 25 | 28.4% | 81.4% | ||
| Q4 24 | 46.1% | 79.8% | ||
| Q3 24 | 23.1% | 82.1% | ||
| Q2 24 | 28.4% | 84.5% | ||
| Q1 24 | 24.2% | 85.3% |
营业利润率OPKRILY
| Q4 25 | -25.8% | 32.3% | ||
| Q3 25 | 31.7% | 30.4% | ||
| Q2 25 | -38.3% | 5.7% | ||
| Q1 25 | -44.8% | -31.2% | ||
| Q4 24 | -18.0% | -69.2% | ||
| Q3 24 | 8.2% | -36.4% | ||
| Q2 24 | -33.9% | -90.8% | ||
| Q1 24 | -41.2% | -6.1% |
净利率OPKRILY
| Q4 25 | -21.1% | 47.9% | ||
| Q3 25 | 14.3% | 42.3% | ||
| Q2 25 | -94.7% | 74.1% | ||
| Q1 25 | -45.1% | -5.1% | ||
| Q4 24 | 7.6% | -2.3% | ||
| Q3 24 | 14.3% | -126.1% | ||
| Q2 24 | -5.7% | -169.4% | ||
| Q1 24 | -47.1% | -18.7% |
每股收益（稀释后）OPKRILY
| Q4 25 | $-0.04 | $2.78 | ||
| Q3 25 | $0.03 | $2.91 | ||
| Q2 25 | $-0.19 | $4.50 | ||
| Q1 25 | $-0.10 | $-0.39 | ||
| Q4 24 | $0.02 | $-0.01 | ||
| Q3 24 | $0.03 | $-9.39 | ||
| Q2 24 | $-0.01 | $-14.35 | ||
| Q1 24 | $-0.12 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $364.4M | $226.6M |
| 总债务越低越好 | $344.0M | $1.4B |
| 股东权益账面价值 | $1.3B | $-171.5M |
| 总资产 | $1.9B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势，按日历期对齐
现金及短期投资OPKRILY
| Q4 25 | $364.4M | $226.6M | ||
| Q3 25 | $412.0M | $184.2M | ||
| Q2 25 | $267.3M | $267.4M | ||
| Q1 25 | $428.8M | $138.3M | ||
| Q4 24 | $426.6M | $146.9M | ||
| Q3 24 | $400.1M | $159.2M | ||
| Q2 24 | $40.6M | $236.9M | ||
| Q1 24 | $75.6M | $190.7M |
总债务OPKRILY
| Q4 25 | $344.0M | $1.4B | ||
| Q3 25 | $344.2M | $1.3B | ||
| Q2 25 | $343.3M | $1.3B | ||
| Q1 25 | $439.2M | $1.4B | ||
| Q4 24 | $437.2M | $1.5B | ||
| Q3 24 | $441.0M | — | ||
| Q2 24 | $201.9M | — | ||
| Q1 24 | $350.1M | — |
股东权益OPKRILY
| Q4 25 | $1.3B | $-171.5M | ||
| Q3 25 | $1.3B | $-260.5M | ||
| Q2 25 | $1.3B | $-351.7M | ||
| Q1 25 | $1.3B | $-496.8M | ||
| Q4 24 | $1.4B | $-488.2M | ||
| Q3 24 | $1.4B | $-497.6M | ||
| Q2 24 | $1.4B | $-218.3M | ||
| Q1 24 | $1.3B | $228.4M |
总资产OPKRILY
| Q4 25 | $1.9B | $1.7B | ||
| Q3 25 | $2.0B | $1.7B | ||
| Q2 25 | $2.0B | $1.5B | ||
| Q1 25 | $2.1B | $1.5B | ||
| Q4 24 | $2.2B | $1.8B | ||
| Q3 24 | $2.3B | $2.2B | ||
| Q2 24 | $2.0B | $3.2B | ||
| Q1 24 | $2.0B | $5.0B |
负债/权益比OPKRILY
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.9M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $-28.6M | — |
| 自由现金流率自由现金流/营收 | -19.3% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.29× |
| 过去12个月自由现金流最近4个季度 | $-190.8M | — |
8季度趋势，按日历期对齐
经营现金流OPKRILY
| Q4 25 | $-25.9M | $26.2M | ||
| Q3 25 | $-34.6M | $-60.6M | ||
| Q2 25 | $-83.4M | $-25.6M | ||
| Q1 25 | $-34.6M | $184.0K | ||
| Q4 24 | $-44.4M | $-2.7M | ||
| Q3 24 | $-77.1M | $19.5M | ||
| Q2 24 | $-26.4M | $111.5M | ||
| Q1 24 | $-35.6M | $135.4M |
自由现金流OPKRILY
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-37.8M | — | ||
| Q2 25 | $-86.7M | — | ||
| Q1 25 | $-37.7M | — | ||
| Q4 24 | $-49.8M | — | ||
| Q3 24 | $-85.0M | — | ||
| Q2 24 | $-33.7M | — | ||
| Q1 24 | $-40.0M | — |
自由现金流率OPKRILY
| Q4 25 | -19.3% | — | ||
| Q3 25 | -24.9% | — | ||
| Q2 25 | -55.3% | — | ||
| Q1 25 | -25.2% | — | ||
| Q4 24 | -27.1% | — | ||
| Q3 24 | -49.0% | — | ||
| Q2 24 | -18.5% | — | ||
| Q1 24 | -23.0% | — |
资本支出强度OPKRILY
| Q4 25 | 1.8% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 2.6% | — |
现金转化率OPKRILY
| Q4 25 | — | 0.29× | ||
| Q3 25 | -1.60× | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.17× | — | ||
| Q3 24 | -3.10× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
